Sol-Gel Technologies (SLGL) Receivables - Other (2022)
Sol-Gel Technologies (SLGL) posted quarterly Receivables - Other of -$7.8 million for Q4 2022.
Sol-Gel Technologies (SLGL) Receivables - Other (2022) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Receivables - Other for 1 consecutive years, with -$7.8 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Receivables - Other changed N/A year-over-year to -$7.8 million; the TTM figure through Dec 2022 stood at -$7.8 million (changed N/A YoY), while the FY2022 annual figure was -$7.8 million, changed N/A from the prior year.
- Receivables - Other held at -$7.8 million in Q4 2022 per SLGL's latest filing.
- Across five years, Receivables - Other topped out at -$7.8 million in Q4 2022 and bottomed at -$7.8 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Sol-Gel Technologies | 240.26 Mn | 230.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -7.80 Mn |
| Dec 31, 2022 | -7.80 Mn |